NCT04154163
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +41 more
- Locations
-
- NHS Tayside and University of Dundee Dundee, Scotland, United Kingdom
Clinical trial condition
Lung Cancer, Non-small Cell
Explore clinical trials studying Lung Cancer, Non-small Cell. Study availability and eligibility vary by location and protocol.
44 public trials
12 recruiting studies
Lung Cancer, Non-small Cell trial results
NCT00290355
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Edegem, Belgium
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site Leuven, Belgium
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Newark, Delaware, United States
- GSK Investigational Site Springfield, Illinois, United States
- GSK Investigational Site Rochester, Minnesota, United States
- GSK Investigational Site Paterson, New Jersey, United States
NCT00065182
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
NCT00619424
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Nashville, Tennessee, United States
- GSK Investigational Site Orbassano (TO), Piedmont, Italy
NCT00528281
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
- GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
- GSK Investigational Site Orbassano (TO), Piedmont, Italy
- GSK Investigational Site Poznan, Poland
NCT00678977
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Essen, North Rhine-Westphalia, Germany
- GSK Investigational Site Newcastle upon Tyne, Northumberland, United Kingdom
NCT00866528
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Chicago, Illinois, United States
- GSK Investigational Site Columbus, Ohio, United States
- GSK Investigational Site Sutton, Surrey, United Kingdom
- GSK Investigational Site Newcastle upon Tyne, United Kingdom
NCT01362296
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Orange, California, United States
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Jacksonville, Florida, United States
Completed
NSCLC Burden of Illness Study
NCT01772225
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified